Clinical Trial Update: Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety, tolerability, and early signals of efficacy for AVT001 in Type 1 Diabetes from Phase 1/2 results. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• AVT001

Snippet

Sponsor: Avotres Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-05